Cardinal Health (NYSE:CAH) changed -0.40% to recent value of $42.75. The stock transacted 6580512 shares during most recent day however it has an average volume of 2851.45K shares. It spotted trading -26.68% off 52-week high price. On the other end, the stock has been noted 1.76% away from the low price over the last 52-weeks.
On Aug. 7, 2019, Cardinal Health (NYSE:CAH) declared that Dean Scarborough, former Chairman and Chief Executive Officer of Avery Dennison Corporation, and John Weiland, former Vice Chairman, President and Chief Operating Officer of C.R. Bard, will join its Board of Directors effective September 1. Mr. Scarborough and Mr. Weiland are highly accomplished executives with decades of extraordinary experience leading major global corporations. These appointments will bring the total number of Cardinal Health directors to 12, 11 of whom will be independent. Both Mr. Scarborough and Mr. Weiland will serve as members of Cardinal Health’s Audit Committee.
We are pleased to welcome Dean Scarborough and John Weiland to Cardinal Health’s Board of Directors, said Gregory Kenny, Chairman of the Board. Dean and John are exceptionally well-regarded and accomplished leaders with significant board experience, deep expertise and outstanding track records having led industry-leading corporations. In addition, Dean brings to our Board extensive knowledge in global manufacturing and distribution while John brings a highly successful background in healthcare and medical products. We look forward to their valuable insights and judgment in helping us to successfully execute our long-term strategic growth plans.
CAH has a gross margin of 4.80% and an operating margin of 0.50% while its profit margin remained 0.00% for the last 12 months. Its earnings per share (EPS) expected to touch remained -150.40% for this year while earning per share for the next 5-years is expected to reach at 3.27%.
The company has 301.68M of outstanding shares and 297.04M shares were floated in the market. According to the most recent quarter its current ratio was 1.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -6.63% from the mean of 20 days, -5.77% from mean of 50 days SMA and performed -12.34% from mean of 200 days price. Company’s performance for the week was -6.52%, -9.43% for month and YTD performance remained -4.15%.